Skip to main content
. 2023 Oct 22;31(1):605–613. doi: 10.1245/s10434-023-14405-3

Table 1.

MLN status according to the type of digestive resection, FIGO stage, and pathology characteristics

Patients with negative MLN n (%) Patients with positive MLN n (%) p Value
Type of bowel resection
 Right colectomy 1 (2.27) 1 (2.27) NA
 Left colectomy 2 (4.55) 1 (2.27)
 Recto-sigmoidectomy 10 (22.73) 10 (22.73)
 Multiple/total colectomy 3 (6.82) 7 (15.91)
 Small bowel resection 1 (2.27) 0 (0)
 Other 2 (4.55) 6 (13.64)
BRCA mutations
 Yes 2 4 0.0753
 No 9 7
FIGO stage
 III 16 (36.36) 21 (47.73) 0.58
 IVA 2 (66.7) 1 (33.3)
 IVB 1 (25.0) 3 (75.0)
Histologic type
 Serous 16 (36.36) 21 (47.73) 0.46
 Endometroid 1 (2.27) 0 (0)
 Other 2 (4.55) 4 (9.09)
Pathologic tumor grade
 G1 4 (9.09) 4 (9.09) 0.706
 G2 1 (2.27) 3 (6.82)
 G3 14 (31.82) 18 (40.91)
Depth of bowel infiltration
 No infiltration 6 (13.64) 1 (2.27)
 Serosa 8 (18.18) 12 (27.27)
 Subserosa 0 (0) 4 (9.09) 0.133
 Muscularis propria 2 (4.55) 3 (6.82)
 Mucosa 1 (2.27) 2 (4.55)
 Not specified in the anatomopathologic report 2 (4.55) 3 (6.82)
Pelvic lymph node status
 Negative 7 (31.82) 2 (9.09) 0.421
 Positive 8 (36.36) 5 (22.73)
Lombo-aortic lymph node status
 Negative 6 (30) 2 (10) 0.067
 Positive 4 (20) 8 (40)

MLN, mesenteric lymph nodes; FIGO, International Federation of Gynecology and Obstetrics